FEEDING BEHAVIOR AND BODY WEIGHT DEVELOPMENT: LESSONS FROM RATS SUBJECTED TO GASTRIC BYPASS SURGERY OR HIGH-FAT DIET

被引:0
作者
Furnes, M. W. [1 ]
Zhao, C. -M. [1 ]
Stenstrom, B. [1 ]
Arum, C. -J. [1 ,2 ]
Tommeras, K. [1 ]
Kulseng, B. [2 ]
Chen, D. [1 ]
机构
[1] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, N-7034 Trondheim, Norway
[2] St Olavs Univ Hosp, Dept Surg, Trondheim, Norway
来源
JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY | 2009年 / 60卷
关键词
gastric bypass; high-fat diet; obesity; stomach; food intake; weight loss; ghrelin; obestatin; ENTEROCHROMAFFIN-LIKE CELLS; GROWTH-HORMONE-SECRETION; GHRELIN-PRODUCING CELLS; CHROMOGRANIN-A; FOOD-INTAKE; ENERGY-METABOLISM; ACYLATED PEPTIDE; OBESTATIN; ENDOCRINE; STOMACH;
D O I
暂无
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Weight loss treatments include diets, drugs, physical training, and surgery, namely bariatric or obesity surgery. The current standard for bariatric surgery is gastric bypass. There are common beliefs that gastric bypass induces body weight loss because of a reduced food intake and that high-fat diet induces overweight and obesity because of overnutrition. The principal aim of the studies on rats summarized herein was to better understand the physiological mechanisms by which gastric bypass achieves body weight loss and by which high-Cat diet induces obesity. The results indicated that gastric bypass efficiently reduced body weight, particularly the fat compartment, which was unlikely to be caused by early satiety, reduced food intake or malabsorption, and that large meal size, but not overnutrition, was mainly responsible For high-fat diet-induced obesity. It was unclear whether gastric ghrelin, obestatin and/or amine in the A-like cells were involved in this context.
引用
收藏
页码:25 / 31
页数:7
相关论文
共 65 条
  • [31] Foresight report on obesity
    King, David
    [J]. LANCET, 2007, 370 (9601) : 1754 - 1754
  • [32] Drug Insight: the functions of ghrelin and its potential as a multitherapeutic hormone
    Kojima, M
    Kangawa, K
    [J]. NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2006, 2 (02): : 80 - 88
  • [33] Ghrelin is a growth-hormone-releasing acylated peptide from stomach
    Kojima, M
    Hosoda, H
    Date, Y
    Nakazato, M
    Matsuo, H
    Kangawa, K
    [J]. NATURE, 1999, 402 (6762) : 656 - 660
  • [34] Konturek SJ, 2004, J PHYSIOL PHARMACOL, V55, P137
  • [35] Ghrelin affects gastrectomy-induced decrease in UCP1 and β3-AR mRNA expression in mice
    Lindqvist, Andreas
    de la Cour, Charlotta Dornonville
    Hakanson, Rolf
    Erlanson-Albertsson, Charlotte
    [J]. REGULATORY PEPTIDES, 2007, 142 (1-2) : 24 - 28
  • [36] Liu YJ, 1997, ANNU REV NEUROSCI, V20, P125
  • [37] Martin LF, 2004, OBES SURG, V14, P15
  • [38] A surgical rat model of human Roux-en-Y gastric bypass
    Meguid, MM
    Ramos, EJB
    Suzuki, S
    Xu, YA
    George, ZM
    Das, UN
    Hughes, K
    Quinn, R
    Chen, C
    Marx, W
    Cunningham, PRG
    [J]. JOURNAL OF GASTROINTESTINAL SURGERY, 2004, 8 (05) : 621 - 630
  • [39] Physical activity prevented age-related decline in energy metabolism in genetically obese and diabetic rats, but not in control rats
    Miyasaka, K
    Ichikawa, M
    Kawanami, T
    Kanai, S
    Ohta, M
    Sato, N
    Ebisawa, H
    Funakoshi, A
    [J]. MECHANISMS OF AGEING AND DEVELOPMENT, 2003, 124 (02) : 183 - 190
  • [40] Current status of medical and surgical therapy for obesity
    Mun, EC
    Blackburn, GL
    Matthews, JB
    [J]. GASTROENTEROLOGY, 2001, 120 (03) : 669 - 681